Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.
about
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic painIncreased μ-opioid receptor expression in metastatic lung cancerGestational naltrexone ameliorates fetal ethanol exposures enhancing effect on the postnatal behavioral and neural response to ethanol.Synergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs)Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone.Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer.Antagonism of the Met5-enkephalin-opioid growth factor receptor-signaling axis promotes MSC to differentiate into osteoblasts.Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.Targeted overexpression of OGFr in epithelium of transgenic mice suppresses cell proliferation and impairs full-thickness wound closure.Targeting the opioid growth factor: opioid growth factor receptor axis for treatment of human ovarian cancer.The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol.
P2860
Q28307673-142FB73B-73E7-4B0B-8657-6390141A2D46Q33951500-7C30DDFA-992C-4F0C-8B03-A4561122D5BCQ36409468-8FB2DD62-5E4A-430F-BDC4-27096C941562Q37521866-94DB2D87-9920-431D-A0EF-4261301397EAQ38647159-50426DB2-577F-4D78-9F37-4220B7066ED7Q39397468-C9608E9E-DEA5-418A-A0A4-3ADA47F0B79BQ40189040-542C1D95-5DAC-4A72-9032-19A2B9E26D65Q42799555-68308F6E-81A1-4686-9A5C-555EE0363895Q44031670-882B4809-4A0C-4275-9E7A-6092F81F51CFQ44340325-FC176B30-52B6-4EFD-AAEC-834F0300BE9EQ50138967-69A2C424-8C17-40E9-98DA-9CDF73A1A2D1
P2860
Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Low-dose naltrexone targets th ...... e from a tissue culture model.
@en
Low-dose naltrexone targets th ...... e from a tissue culture model.
@nl
type
label
Low-dose naltrexone targets th ...... e from a tissue culture model.
@en
Low-dose naltrexone targets th ...... e from a tissue culture model.
@nl
prefLabel
Low-dose naltrexone targets th ...... e from a tissue culture model.
@en
Low-dose naltrexone targets th ...... e from a tissue culture model.
@nl
P2093
P2860
P921
P356
P1476
Low-dose naltrexone targets th ...... e from a tissue culture model.
@en
P2093
Ian S Zagon
Patricia J McLaughlin
Renee N Donahue
P2860
P304
P356
10.1258/EBM.2011.011121
P577
2011-08-01T00:00:00Z